Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-38304
Development. May 1, 2008; 135 (10): 1735-43.

Controlling morpholino experiments: don''t stop making antisense.

Eisen JS , Smith JC .


Abstract
One of the most significant problems facing developmental biologists who do not work on an organism with well-developed genetics - and even for some who do - is how to inhibit the action of a gene of interest during development so as to learn about its normal biological function. A widely adopted approach is to use antisense technologies, and especially morpholino antisense oligonucleotides. In this article, we review the use of such reagents and present examples of how they have provided insights into developmental mechanisms. We also discuss how the use of morpholinos can lead to misleading results, including off-target effects, and we suggest controls that will allow researchers to interpret morpholino experiments correctly.

PubMed ID: 18403413
Article link: Development.
Grant support: R01 NS023915-21A1S1 NINDS NIH HHSBiotechnology and Biological Sciences Research CouncilWellcome Trust , R01 NS023915-21A1S1 NINDS NIH HHSBiotechnology and Biological Sciences Research CouncilWellcome Trust



My Xenbase: [ Log-in / Register ]
version: [4.5.0]

Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556